Features of VEGF and IL-6 expression in patients with inflammatory breast cancer considering molecular-biological characteristics

por Smolanka, Ivan Ivanovich, Bagmut, Irina Yuriivna, Movchan, Oleksii Volodimirovich, Sheremet, Michael Ivanovich, Bilyi, Oleksandr Mykolayovych, Lyashenko, Andriy Oleksandrovich, Dosenko, Irina Viktorivna, Loboda, Anton Dmitrovich, Ivankova, Oksana Mykolaivna, Kolisnyk, Igor Leonidovich
Publicado 2023

Breast cancer relapses considering molecular biological characteristics

por Smolanka, Ivan Ivanovich, Movchan, Oleksii Volodimirovich, Bagmut, Irina Yuriivna, Sheremet, Michael Ivanovich, Kolisnyk, Igor Leonidovich, Dosenko, Irina Viktorivna, Lyashcnko, Andriy Oleksandrovich, Ivankova, Oksana Mykolaivna, Loboda, Anton Dmitrovich, Shidlovskyi, Oleksandr Viktorovich
Publicado 2023

Main factors determining the use of free MS-TRAM and DIEP flaps and comparing the results of breast reconstruction

por Smolanka, Ivan Ivanovich, Galych, Sergiy Petrovich, Movchan, Oleksii Volodimirovich, Bagmut, Irina Yuriivna, Sheremet, Michael Ivanovich, Kolisnyk, Igor Leonidovich, Bagmut, Oleksandr Vasyliovych, Lyashenko, Andriy Oleksandrovich, Dosenko, Irina Viktorivna, Ivankova, Oksana Mykolaivna, Maksymyuk, Vitaliy Vasilyevich, Tarabanchuk, Volodimir Volodimirovich
Publicado 2023

HER2/positive and HER2/low in inflammatory breast cancer recurrence

por Movchan, Oleksii Volodimirovich, Bagmut, Irina Yuriivna, Shipko, Andriy Fedorovich, Smolanka (Senior), Ivan Ivanovich, Sheremet, Michael Ivanovich, Kolisnyk, Igor Leonidovich, Bagmut, Oleksandr Vasyliovych, Lyashenko, Andriy Oleksandrovich, Loboda, Anton Dmitrovich, Ivankova, Oksana Mykolaivna, Dosenko, Irina Viktorivna, Lazaruk, Oleksandr Volodimirovich, Gyrla, Yan Viktorovich, Bilookyi, Oleksandr Vyacheslavovich
Publicado 2022